Mirion Technologies and Competitor Analysis Report

Overview

Mirion Technologies is a prominent provider of radiation measurement and detection systems, serving diverse industries such as nuclear, defense, medical, and research. The company was established through a series of mergers and acquisitions between 1950 and 2004, officially incorporating in December 2005. Headquartered in Atlanta, Georgia, Mirion operates with a workforce of around 2,800 employees. The company is dedicated to leveraging its deep understanding of ionizing radiation to progress innovation and safety in radiation science.

Products and Services

Mirion Technologies offers a broad suite of technologies aimed at radiation safety and measurement, catering to applications like nuclear power generation, medical imaging, and border security. The company’s solutions are organized into several business units: Radiation Monitoring, Health Physics, Sensing, Imaging, and Dosimetry Services. In July 2022, Mirion launched the Mirion Medical division, which is focused on improving the safety of medical diagnostics and treatments.

Financial Performance

Mirion went public on October 21, 2021, with an initial public offering (IPO) valued at $2.6 billion and raised $1.5 billion. The company's financial health is robust, illustrated by a 10.4% increase in its fourth-quarter revenues to $254.3 million as of 2024. By February 2025, Mirion's market capitalization was $3.14 billion, with an enterprise value of $3.65 billion.

Key Personnel

Thomas Logan: Founding Chairman, CEO, and Director since 2005, guiding clarity and risk management.

Emmanuelle Lee: Chief Legal Officer and Chief Compliance Officer since 2011.

Brian Schopfer: Chief Financial Officer since 2020, joined in 2015.

Shelia Webb: Chief Digital Officer as of October 2023, previously Chief Technology Officer.

Loic Eloy: President, Technologies Group since 2022, focusing on strategic growth.

Alison Ulrich: Chief Human Resources Officer, appointed in April 2022.

James Cocks: Chief Technology Officer, appointed in October 2023.

Erin Schesny: Chief Marketing Officer, leading marketing strategies since October 2023.

Mark Siviter: Chief Revenue Officer, managing sales since August 2024.

Christopher Moore: Chief Accounting Officer, appointed in March 2022.

Strategic Alliances and Milestones

Mirion has broadened its capabilities into healthcare, earning notable contracts like the Sizewell C nuclear power project in the UK. Growth initiatives are fueled by partnerships with industry leaders aiming to solve radiation safety issues and propel scientific advancement.

Contact Information

For any inquiries or collaboration opportunities, visit their website: [https://www.mirion.com](https://www.mirion.com) or use their dedicated contact page: [Mirion Contact](https://www.mirion.com/contact).

Competitor Profile

Revvity (NYSE: RVTY)

A formidable competitor, Revvity provides comprehensive health science solutions from discovery to diagnosis. The company's market cap stands at $13.99 billion with revenues of $2.76 billion, showcasing strong financial stability. Revvity excels in biotechnology and pioneering biomedical research, positioning it competitively against Mirion’s scientific endeavors.

Avantor (NYSE: AVTR)

Avantor has significant industry influence, offering pivotal products and services to the biopharma and healthcare sectors. With a market cap of $11.91 billion and $6.78 billion in revenue, Avantor provides a substantial alternative to Mirion's laboratory and diagnostics equipment.

Bio-Rad Laboratories (NYSE: BIO)

Specializing in life sciences research and clinical diagnostics, Bio-Rad Laboratories competes with Mirion’s medical diagnostic solutions. Their solid market role stems from a targeted product portfolio in clinical diagnostics, although their $8.74 billion market cap is lower relative to other competitors.

Nova (NASDAQ: NVMI)

Nova Ltd. is known for semiconductor manufacturing and process control solutions, aligning with Mirion's precision monitoring devices. With a focus on advanced metrology solutions, Nova offers technological innovations parallel to Mirion’s radiation detection services.

Vontier (NYSE: VNT)

An industrial technology entity focusing on mobility ecosystems, Vontier deals in measurement and environmental sensors. While Vontier’s primary competency does not directly overlap with Mirion, it offers indirect competition through its technological and measurement innovations.

Market Position and Industry Insights

Mirion Technologies maintains a unique position in the radiation detection domain by specializing in precise monitoring solutions for medical, nuclear, and industrial use. However, competitors utilize broader product portfolios and larger operational scales to penetrate various scientific and technological markets, emphasizing the need for Mirion to enhance its core innovations and strategic partnerships to uphold its competitive edge.

This comprehensive profile underscores the competitive landscape and highlights strategic insights crucial for engaging with Mirion Technologies.